= Special COVID-19 =
Drug development - Coronavirus / SARS-CoV2 samples
CoV2-SARS drug development studies may require the use of samples of the virus or infected human cells. These samples are made available in some cases under authorization from health care facilities such as hospitals.
• A specific regulatory process is required for approval of projects
Further details on the project may be requested directly by the expert. You will be able to exchange directly with the experts after filling in the form below.
Please answer all questions below to specify your requirements
Please answer all questions. If you are not logged in, you will be redirected.